American Society Of Health-System Pharmacists issued the following announcement on Feb. 21.
Recent podcast episode: Prioritizing Prickly Pain Policy
This episode is very relevant to pharmacists who frequently treat patients or interact with patients in pain. Not all pharmacists are intimately familiar with the FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), which is the official comprehensive pain education strategy essential to frontline providers in order to ensure that patients receive and understand the Medication Guides and information regarding safe use of opioid medications. Listen here to learn more: https://hubs.ly/Q01CW-_W0
Original source can be found here.
Alerts Sign-up